Procalcitonin in young febrile infants for the detection of Serious bacterial infections

Pediatrics

Volumn 122, Issue 4, 2008, Pages 701-710

  Maniaci, Vincenzo ^a   Dauber, Andrew ^a   Weiss, Scott ^a   Nylen, Eric ^b,c   Becker, Kenneth L ^b,c   Bachur, Richard ^a,d  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

^d Division of Emergency Medicine   (United States)

Author keywords

Bacteremia; Diagnostic tests; Fever; Infant; Procalcitonin; Serious bacterial infection; Urinary tract infection

Indexed keywords

PROCALCITONIN; BIOLOGICAL MARKER; CALCITONIN; GLYCOPROTEIN; PROTEIN PRECURSOR;

ARTICLE; ASSAY; AUTOMATION; BACTEREMIA; BACTERIAL INFECTION; BLOOD LEVEL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE CLASSIFICATION; DISEASE SEVERITY; EMERGENCY WARD; FEMALE; FEVER; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NEWBORN; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PNEUMONIA; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; REFERENCE VALUE; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; URBAN POPULATION; URINARY TRACT INFECTION; VIRUS INFECTION; BLOOD; COMPARATIVE STUDY; DIFFERENTIAL DIAGNOSIS; FOLLOW UP; IMMUNOASSAY; ROC CURVE;

BACTERIAL INFECTIONS; BIOLOGICAL MARKERS; CALCITONIN; DIAGNOSIS, DIFFERENTIAL; FEMALE; FEVER; FOLLOW-UP STUDIES; GLYCOPROTEINS; HUMANS; IMMUNOASSAY; INFANT; MALE; PROSPECTIVE STUDIES; PROTEIN PRECURSORS; ROC CURVE;

EID: 54049124100     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2007-3503     Document Type: Article

References (69)

1. Bachur RG, Harper MB. Predictive model for serious bacterial infections among infants younger than 3 months of age. Pediatrics. 2001;108(2):311-316
2. Baker MD, Bell LM, Avner JR. Outpatient management without antibiotics of fever in selected infants. N Engl J Med. 1993; 329(20):1437-1441
3. Baraff LJ. Outpatient management of fever in selected infants. N Engl JMed. 1994;330(13):938-939
4. Baraff LJ, Bass JW, Fleisher GR, et al. Practice guideline for the management of infants and children 0 to 36 months of age with fever without source. Ann Emerg Med. 1993;22(7): 1198-1210
5. Baskin MN. The prevalence of serious bacterial infections by age in febrile infants during the first 3 months of life. Pediatr Ann. 1993;22(8):462-466
6. Byington CL, Enriquez FR, Hoff C, et al. Serious bacterial infections in febrile infants 1 to 90 days old with and without viral infections. Pediatrics. 2004;113(6):1662-1666
7. Jaskiewicz JA, McCarthy CA, Richardson AC, et al. Febrile infants at low risk for serious bacterial infection: an appraisal of the Rochester criteria and implications for management. Pediatrics. 1994;94(3):390-396
8. Baskin MN, O'Rourke EJ, Fleisher GR. Outpatient treatment of febrile infants 28 to 89 days of age with intramuscular administration of ceftriaxone. J Pediatr. 1992;120(1):22-27
9. Bonadio WA, Hennes H, Smith D, et al. Reliability of observation variables in distinguishing infectious outcome of febrile young infants. Pediatr Infect Dis J. 1993;12(2):111-114
10. Baker MD, Avner JR, Bell LM. Failure of infant observation scales in detecting serious illness in febrile, 4- to 8-week-old infants. Pediatrics. 1990;85(6):1040-1043
11. Pantell RH, Newman TB, Bernzweig J, et al. Management and outcomes of care of fever in early infancy. JAMA. 2004; 291(10):1203-1212
12. Baskin MN, Fleisher GR, O'Rourke EJ. Identifying febrile infants at risk for a serious bacterial infection. J Pediatr. 1993; 123(3):489-490
13. Baraff L, Schriger D, Bass J, et al. Practice guideline for the management of infants and children 0 to 36 months of age with fever without source. Pediatrics. 1993;92(1):1-12
14. Garra G, Cunningham SJ, Crain EF. Reappraisal of criteria used to predict serious bacterial illness in febrile infants less than 8 weeks of age. Acad Emerg Med. 2005;12(10):921-925
15. Kadish HA, Loveridge B, Tobey J, Bolte RG, Corneli HM. Applying outpatient protocols in febrile infants 1-28 days of age: can the threshold be lowered? Clin Pediatr (Phila). 2000; 39(2):81-88
16. Bauchner H, Pelton SI. Management of the young febrile child: a continuing controversy. Pediatrics. 1997;100(1):137-138
17. Roberts KB. Young, febrile infants: a 30-year odyssey ends where it started. JAMA. 2004;291(10):1261-1262
18. Bleeker SE, Moons KG, Derksen-Lubsen G, Grobbee DE, Moll HA. Predicting serious bacterial infection in young children with fever without apparent source. Acta Paediatr. 2001;90(11): 1226 -1232
19. Galetto-Lacour A, Zamora SA, Gervaix A. Bedside procalcitonin and C-reactive protein tests in children with fever without localizing signs of infection seen in a referral center. Pediatrics. 2003;112(5):1054-1060
20. Gendrel D, Raymond J, Coste J, et al. Comparison of procalcitonin with C-reactive protein, interleukin 6 and interferon-α for differentiation of bacterial vs viral infections. Pediatr Infect Dis J. 1999;18(10):875-881
21. Hatherill M, Tibby SM, Sykes K, Turner C, Murdoch IA. Diagnostic markers of infection: comparison of procalcitonin with C reactive protein and leucocyte count. Arch Dis Child. 1999; 81(5):417-421
22. Pulliam PN, Attia MW, Cronan KM. C-reactive protein in febrile children 1 to 36 months of age with clinically undetect- able serious bacterial infection. Pediatrics. 2001;108(6): 1275-1279
23. Hsiao AL, Baker MD. Fever in the new millennium: a review of recent studies of markers of serious bacterial infection in febrile children. Curr Opin Pediatr. 2005;17(1):56-61
24. Fernandez Lopez A, Luaces Cubells C, Garcia Garcia JJ, Fernandez Pou J. Procalcitonin in pediatric emergency departments for the early diagnosis of invasive bacterial infections in febrile infants: results of a multicenter study and utility of a rapid qualitative test for this marker. Pediatr Infect Dis J. 2003; 22(10):895-903
25. Lacour AG, Gervaix A, Zamora SA, et al. Procalcitonin, IL-6, IL-8, IL-1 receptor antagonist and C-reactive protein as iden- tificators of serious bacterial infections in children with fever without localising signs. Eur J Pediatr. 2001;160(2):95-100
26. Dubos F, Moulin F, Gajdos V, et al. Serum procalcitonin and other biologic markers to distinguish between bacterial and aseptic meningitis. J Pediatr. 2006;149(1):72-76
27. Gendrel D, Raymond J, Assicot M, et al. Measurement of procalcitonin levels in children with bacterial or viral meningitis. Clin Infect Dis. 1997;24(6):1240-1242
28. Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet. 1993;341(8844): 515-518
29. Thayyil S, Shenoy M, Hamaluba M, Gupta A, Frater J, Verber IG. Is procalcitonin useful in early diagnosis of serious bacterial infections in children? Acta Paediatr. 2005;94(2):155-158
30. Andreola B, Bressan S, Callegaro S, Liverani A, Plebani M, Da Dalt L. Procalcitonin and C-reactive protein as diagnostic markers of severe bacterial infections in febrile infants and children in the emergency department. Pediatr Infect Dis J. 2007;26(8): 672-677
31. Snider RH, Silva OL, Moor CF, Becker KL. Immunochemical heterogeneity of calcitonin in man: effect on radioimmunoas- say. Clin Chim Acta. 1977;76(1):1-14
32. BRAHMS. Welcome to PCT. Available at: www.procalcitonin.com. Accessed September 1, 2007
33. Kuppermann N, Fleisher GR, Jaffe DM. Predictors of occult pneumococcal bacteremia in young febrile children. Ann Emerg Med. 1998;31(6):679-687
34. BonadioWA, SmithD, Carmody J. Correlating CBC profile and infectious outcome: a study of febrile infants evaluated for sepsis. Clin Pediatr (Phila). 1992;31(10):578 -582
35. Bonsu BK, Chb M, Harper MB. Identifying febrile young infants with bacteremia: is the peripheral white blood cell count an accurate screen? Ann Emerg Med. 2003;42(2):216-225
36. Berger RM, Berger MY, van Steensel-Moll HA, Dzoljic Danilovic G, Derksen-Lubsen G. A predictive model to estimate the risk of serious bacterial infections in febrile infants. Eur J Pediatr. 1996;155(6):468-473
37. Maheshwari N. How useful is C-reactive protein in detecting occult bacterial infection in young children with fever without apparent focus? Arch Dis Child. 2006;91(6):533-535
38. Peltola H, Jaakkola M. C-reactive protein in early detection of bacteremic versus viral infections in immunocompetent and compromised children. J Pediatr. 1988;113(4):641-646
39. Putto A, Ruuskanen O, Meurman O, et al. C reactive protein in the evaluation of febrile illness. Arch Dis Child. 1986;61(1): 24-29
40. Bleeker SE, Derksen-Lubsen G, Grobbee DE, Donders AR, Moons KG, Moll HA. Validating and updating a prediction rule for serious bacterial infection in patients with fever without source. Acta Paediatr. 2007;96(1):100-104
41. Becker KL, Nylen ES, White JC, Muller B, Snider RH Jr. Clinical review 167: procalcitonin and the calcitonin gene family of peptides in inflammation, infection, and sepsis: a journey from calcitonin back to its precursors. J Clin Endocrinol Metab. 2004;89(4):1512-1525
42. Rey C, Los Arcos M, Concha A, et al. Procalcitonin and C-rective protein as markers of systemic inflammatory response syndrome severity in critically ill children. Intens Care Med. 2007;33(3):477-484
43. Athhan F, Akagunduz B, Genel F, Bak M, Can D. Procalcitonin: a marker of neonatal sepsis. JTrop Pediatr. 2002; 48(1):10-14
44. Han YY, Doughty LA, Kofos D, Sasser H, Carcillo JA. Procalcitonin is persistently increased among children with poor out come from bacterial sepsis. Pediatr Crit Care Med. 2003;4(1): 21-25
45. Hatherill M, Tibby SM, Turner C, Ratnavel N, Murdoch IA. Procalcitonin and cytokine levels: relationship to organ failure and mortality in pediatric septic shock. Crit Care Med. 2000; 28(7):2591-2594
46. Leclerc F, Cremer R, Noizet O. Procalcitonin as a diagnostic and prognostic biomarker of sepsis in critically ill children. Pediatr Crit Care Med. 2003;4(2):264-266
47. Nylen E, Muller B, Becker KL, Snider R. The future diagnostic role of procalcitonin levels: the need for improved sensitivity. Clin Infect Dis. 2003;36(6):823-824
48. van Rossum AM, Wulkan RW, Oudesluys-Murphy AM. Procalcitonin as an early marker of infection in neonates and children. Lancet Infect Dis. 2004;4(10):620-630
49. Moulin F, Raymond J, Lorrot M, et al. Procalcitonin in children admitted to hospital with community acquired pneumonia. Arch Dis Child. 2001;84(4):332-336
50. Michelow IC, Katz K, McCracken GH, Hardy RD. Systemic cytokine profile in children with community-acquired pneumonia. Pediatr Pulmonol. 2007;42(7):640-645
51. Korppi M. Non-specific host response markers in the differentiation between pneumococcal and viral pneumonia: what is the most accurate combination? Pediatr Int. 2004;46(5): 545-550
52. Michelow IC, Olsen K, Lozano J, et al. Epidemiology and clinical characteristics of community-acquired pneumonia in hospitalized children. Pediatrics. 2004;113(4):701-707
53. Ray P, Badarou-Acossi G, Viallon A, et al. Accuracy of the cerebrospinal fluid results to differentiate bacterial from non- bacterial meningitis, in case of negative Gram-stained smear. Am J Emerg Med. 2007;25(2):179-184
54. Dubos F, Moulin F, Raymond J, Gendrel D, Breart G, Chalumeau M. Distinction between bacterial and aseptic meningitis in children: refinement of a clinical decision rule [in French]. Arch Pediatr. 2007;14(5):434-438
55. Nathan BR, Scheld WM. The potential roles of C-reactive protein and procalcitonin concentrations in the serum and cere- brospinal fluid in the diagnosis of bacterial meningitis. Curr Clin Top Infect Dis. 2002;22:155-165
56. Jereb M, Muzlovic I, Hojker S, Strle F. Predictive value of serum and cerebrospinal fluid procalcitonin levels for the diagnosis of bacterial meningitis. Infection. 2001;29(4):209-212
57. Schwarz S, Bertram M, Schwab S, Andrassy K, Hacke W. Serum procalcitonin levels in bacterial and abacterial meningitis. Crit Care Med. 2000;28(6):1828-1832
58. Gendrel D, Bohuon C. Procalcitonin, a marker of bacterial infection. Infection. 1997;25(3):133-134
59. Gervaix A, Galetto-Lacour A, Gueron T, et al. Usefulness of procalcitonin and C-reactive protein rapid tests for the management of children with urinary tract infection. Pediatr Infect Dis J. 2001;20(5):507-511
60. Hellerstein S. Acute urinary tract infection: evaluation and treatment. Curr Opin Pediatr. 2006;18(2):134-138
61. Leroy S, Adamsbaum C, Marc E, et al. Procalcitonin as a predictor of vesicoureteral reflux in children with a first febrile urinary tract infection. Pediatrics. 2005;115(6). Available at: www.pediatrics.org/cgi/content/ full/115/6/e706
62. Tuerlinckx D, Vander Borght T, Glupczynski Y, et al. Is procalcitonin a good marker of renal lesion in febrile urinary tract infection? Eur J Pediatr. 2005;164(10):651-652
63. Pecile P, Miorin E, Romanello C, et al. Procalcitonin: a marker of severity of acute pyelonephritis among children. Pediatrics. 2004;114(2). Available at: www.pediatrics.org/cgi/content/full/114/2/e249
64. Kitanovski L, Jazbec J, Hojker S, Gubina M, Derganc M. Diagnostic accuracy of procalcitonin and interleukin-6 values for predicting bacteremia and clinical sepsis in febrile neutropenic children with cancer. Eur J Clin Microbiol Infect Dis. 2006;25(6): 413-415
65. Stryjewski GR, Nylen ES, Bell MJ, et al. Interleukin-6, interleukin-8, and a rapid and sensitive assay for calcitonin precursors for the determination of bacterial sepsis in febrile neutropenic children. Pediatr Crit Care Med. 2005;6(2):129-135
66. Guen CG, Delmas C, Launay E, et al. Contribution of procalcitonin to occult bacteraemia detection in children. Scand J In- fect Dis. 2007;39(2):157-159
67. Carrol ED, Newland P, Riordan FA, Thomson AP, Curtis N, HartCA. Procalcitoninas a diagnostic markerofmeningococcal disease in children presenting with fever and a rash. Arch Dis Child. 2002;86(4):282-285
68. Dandona P, Nix D, Wilson MF, et al. Procalcitonin increase after endotoxin injection in normal subjects. J Clin Endocrinol Metab. 1994;79(6):1605-1608
69. Whang KT, Steinwald PM, White JC, et al. Serum calcitonin precursors in sepsis and systemic inflammation. J Clin Endocrinol Metab. 1998;83(9):3296-3301